Structure

Physi-Chem Properties

Molecular Weight:  360.12
Volume:  354.587
LogP:  1.478
LogD:  1.428
LogS:  -3.007
# Rotatable Bonds:  4
TPSA:  99.13
# H-Bond Aceptor:  7
# H-Bond Donor:  1
# Rings:  3
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.601
Synthetic Accessibility Score:  6.112
Fsp3:  0.421
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  2
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.853
MDCK Permeability:  1.917428380693309e-05
Pgp-inhibitor:  0.315
Pgp-substrate:  0.002
Human Intestinal Absorption (HIA):  0.032
20% Bioavailability (F20%):  0.999
30% Bioavailability (F30%):  0.89

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.23
Plasma Protein Binding (PPB):  71.85697174072266%
Volume Distribution (VD):  1.026
Pgp-substrate:  39.39594650268555%

ADMET: Metabolism

CYP1A2-inhibitor:  0.043
CYP1A2-substrate:  0.093
CYP2C19-inhibitor:  0.061
CYP2C19-substrate:  0.629
CYP2C9-inhibitor:  0.163
CYP2C9-substrate:  0.04
CYP2D6-inhibitor:  0.006
CYP2D6-substrate:  0.051
CYP3A4-inhibitor:  0.252
CYP3A4-substrate:  0.597

ADMET: Excretion

Clearance (CL):  7.569
Half-life (T1/2):  0.915

ADMET: Toxicity

hERG Blockers:  0.001
Human Hepatotoxicity (H-HT):  0.108
Drug-inuced Liver Injury (DILI):  0.902
AMES Toxicity:  0.046
Rat Oral Acute Toxicity:  0.868
Maximum Recommended Daily Dose:  0.261
Skin Sensitization:  0.959
Carcinogencity:  0.539
Eye Corrosion:  0.896
Eye Irritation:  0.965
Respiratory Toxicity:  0.937

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC189609

Natural Product ID:  NPC189609
Common Name*:   Goiazensolide
IUPAC Name:   n.a.
Synonyms:   Goiazensolide; Goyazensolide
Standard InCHIKey:  HTMCLLSRQWRPTN-OKMRAYSCSA-N
Standard InCHI:  InChI=1S/C19H20O7/c1-9(2)17(22)25-14-7-19(4)15(21)6-12(26-19)11(8-20)5-13-16(14)10(3)18(23)24-13/h5-6,13-14,16,20H,1,3,7-8H2,2,4H3/b11-5-/t13-,14+,16+,19-/m1/s1
SMILES:  C=C(C)C(=O)O[C@H]1C[C@]2(C)C(=O)C=C(/C(=C[C@@H]3[C@@H]1C(=C)C(=O)O3)/CO)O2
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL371358
PubChem CID:   5358393
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001283] Terpene lactones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO701 Lychnophora diamantinana Species Asteraceae Eukaryota n.a. n.a. n.a. PMID[23501116]
NPO6743 Piptocoma rufescens Species n.a. n.a. n.a. n.a. n.a. PMID[29350920]
NPO5429 Vachellia pennatula Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO9855 Oricia gabonensis Species Rutaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO10254 Melaleuca cuticularis Species Myrtaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO6743 Piptocoma rufescens Species n.a. n.a. n.a. n.a. n.a. Database[UNPD]
NPO701 Lychnophora diamantinana Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT6530 Cell Line MOLM-13 Homo sapiens Activity = 0.42 uM PMID[520349]
NPT2132 Cell Line EOL1 Homo sapiens Activity = 0.56 uM PMID[520349]
NPT6530 Cell Line MOLM-13 Homo sapiens Activity = 81.8 % PMID[520349]
NPT6530 Cell Line MOLM-13 Homo sapiens Activity = 14.7 % PMID[520349]
NPT6530 Cell Line MOLM-13 Homo sapiens Activity = 3.18 % PMID[520349]
NPT6530 Cell Line MOLM-13 Homo sapiens Activity = 0.392 % PMID[520349]
NPT6530 Cell Line MOLM-13 Homo sapiens Activity = 2.54 % PMID[520349]
NPT6530 Cell Line MOLM-13 Homo sapiens Activity = 0.958 % PMID[520349]
NPT6530 Cell Line MOLM-13 Homo sapiens Activity = 94.6 % PMID[520349]
NPT6530 Cell Line MOLM-13 Homo sapiens Activity = 1.86 % PMID[520349]
NPT6530 Cell Line MOLM-13 Homo sapiens Activity = 0.135 % PMID[520349]
NPT6530 Cell Line MOLM-13 Homo sapiens Activity = 0.203 % PMID[520349]
NPT6530 Cell Line MOLM-13 Homo sapiens Activity = 97.7 % PMID[520349]
NPT6530 Cell Line MOLM-13 Homo sapiens Activity = 1.96 % PMID[520349]
NPT139 Cell Line HT-29 Homo sapiens IC50 = 560.0 nM PMID[520349]
NPT2132 Cell Line EOL1 Homo sapiens IC50 = 1100.0 nM PMID[520349]
NPT6530 Cell Line MOLM-13 Homo sapiens IC50 = 860.0 nM PMID[520349]
NPT2132 Cell Line EOL1 Homo sapiens Activity = 91.7 % PMID[520349]
NPT2132 Cell Line EOL1 Homo sapiens Activity = 1.84 % PMID[520349]
NPT2132 Cell Line EOL1 Homo sapiens Activity = 6.18 % PMID[520349]
NPT2132 Cell Line EOL1 Homo sapiens Activity = 0.306 % PMID[520349]
NPT2132 Cell Line EOL1 Homo sapiens Activity = 3.99 % PMID[520349]
NPT2132 Cell Line EOL1 Homo sapiens Activity = 0.281 % PMID[520349]
NPT2132 Cell Line EOL1 Homo sapiens Activity = 93.3 % PMID[520349]
NPT2132 Cell Line EOL1 Homo sapiens Activity = 2.4 % PMID[520349]
NPT2132 Cell Line EOL1 Homo sapiens Activity = 0.01 % PMID[520349]
NPT2132 Cell Line EOL1 Homo sapiens Activity = 0.0 % PMID[520349]
NPT2132 Cell Line EOL1 Homo sapiens Activity = 99.8 % PMID[520349]
NPT2132 Cell Line EOL1 Homo sapiens Activity = 0.189 % PMID[520349]
NPT139 Cell Line HT-29 Homo sapiens IC50 = 560.0 nM PMID[520351]
NPT983 Protein Complex Nuclear factor NF-kappa-B complex Homo sapiens IC100 = 20.0 uM PMID[520345]
NPT983 Protein Complex Nuclear factor NF-kappa-B complex Homo sapiens pIC100 = -1.3 n.a. PMID[520345]
NPT721 Individual Protein Nuclear factor NF-kappa-B p65 subunit Homo sapiens IC100 = 20.0 uM PMID[520346]
NPT115 Organism Mycobacterium tuberculosis H37Ra Mycobacterium tuberculosis H37Ra MIC = 3.1 ug.mL-1 PMID[520347]
NPT840 Individual Protein Transcriptional activator Myb Gallus gallus IC50 = 625.17 nM PMID[520348]
NPT27 Others Unspecified IC50 = 10050.0 nM PMID[520348]
NPT840 Individual Protein Transcriptional activator Myb Gallus gallus IC50 = 630.0 nM PMID[520348]
NPT21851 SINGLE PROTEIN Dihydroorotate dehydrogenase (fumarate) Leishmania major IC50 = 155800.0 nM PMID[520350]
NPT21851 SINGLE PROTEIN Dihydroorotate dehydrogenase (fumarate) Leishmania major IC50 = 158489.32 nM PMID[520350]
NPT21851 SINGLE PROTEIN Dihydroorotate dehydrogenase (fumarate) Leishmania major Delta Tm = -0.32 degrees C PMID[520350]
NPT21851 SINGLE PROTEIN Dihydroorotate dehydrogenase (fumarate) Leishmania major Delta Tm = -0.84 degrees C PMID[520350]
NPT21851 SINGLE PROTEIN Dihydroorotate dehydrogenase (fumarate) Leishmania major Delta Tm = -1.13 degrees C PMID[520350]
NPT21851 SINGLE PROTEIN Dihydroorotate dehydrogenase (fumarate) Leishmania major Delta Tm = -0.73 degrees C PMID[520350]
NPT21851 SINGLE PROTEIN Dihydroorotate dehydrogenase (fumarate) Leishmania major Delta Tm = -4.19 degrees C PMID[520350]
NPT21851 SINGLE PROTEIN Dihydroorotate dehydrogenase (fumarate) Leishmania major Delta Tm = -6.51 degrees C PMID[520350]
NPT580 Organism Trypanosoma cruzi Trypanosoma cruzi IC50 = 1080.0 nM PMID[520350]
NPT844 Organism Trypanosoma brucei rhodesiense Trypanosoma brucei rhodesiense IC50 = 70.0 nM PMID[520350]
NPT633 Organism Leishmania donovani Leishmania donovani IC50 = 450.0 nM PMID[520350]
NPT2 Others Unspecified IC50 = 1000.0 nM PMID[520351]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC189609 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC197835
1.0 High Similarity NPC303653
1.0 High Similarity NPC291500
1.0 High Similarity NPC140591
0.9468 High Similarity NPC301596
0.9468 High Similarity NPC299396
0.9263 High Similarity NPC172998
0.9208 High Similarity NPC38154
0.9158 High Similarity NPC273197
0.9158 High Similarity NPC234339
0.866 High Similarity NPC474338
0.85 High Similarity NPC187268
0.8438 Intermediate Similarity NPC295312
0.8421 Intermediate Similarity NPC160138
0.84 Intermediate Similarity NPC471462
0.8384 Intermediate Similarity NPC304886
0.8367 Intermediate Similarity NPC125674
0.8367 Intermediate Similarity NPC475838
0.8367 Intermediate Similarity NPC228451
0.8367 Intermediate Similarity NPC59646
0.8351 Intermediate Similarity NPC144133
0.8351 Intermediate Similarity NPC179394
0.8351 Intermediate Similarity NPC475855
0.8283 Intermediate Similarity NPC474247
0.8283 Intermediate Similarity NPC469632
0.8283 Intermediate Similarity NPC470521
0.8182 Intermediate Similarity NPC475912
0.8163 Intermediate Similarity NPC3436
0.8155 Intermediate Similarity NPC185141
0.8155 Intermediate Similarity NPC128733
0.8155 Intermediate Similarity NPC476270
0.8155 Intermediate Similarity NPC474339
0.8155 Intermediate Similarity NPC46998
0.8155 Intermediate Similarity NPC133907
0.8155 Intermediate Similarity NPC110443
0.8155 Intermediate Similarity NPC164598
0.8125 Intermediate Similarity NPC305475
0.8125 Intermediate Similarity NPC475461
0.8119 Intermediate Similarity NPC230800
0.8119 Intermediate Similarity NPC473333
0.8119 Intermediate Similarity NPC279621
0.81 Intermediate Similarity NPC121825
0.81 Intermediate Similarity NPC477131
0.8081 Intermediate Similarity NPC470520
0.8081 Intermediate Similarity NPC32494
0.8081 Intermediate Similarity NPC175842
0.8073 Intermediate Similarity NPC66108
0.8061 Intermediate Similarity NPC225283
0.8039 Intermediate Similarity NPC2666
0.8039 Intermediate Similarity NPC471490
0.8021 Intermediate Similarity NPC67081
0.8021 Intermediate Similarity NPC165162
0.8021 Intermediate Similarity NPC255307
0.8021 Intermediate Similarity NPC471223
0.8021 Intermediate Similarity NPC215364
0.802 Intermediate Similarity NPC36954
0.802 Intermediate Similarity NPC14961
0.802 Intermediate Similarity NPC270013
0.8 Intermediate Similarity NPC179746
0.8 Intermediate Similarity NPC476049
0.8 Intermediate Similarity NPC472755
0.8 Intermediate Similarity NPC469645
0.8 Intermediate Similarity NPC475945
0.8 Intermediate Similarity NPC475871
0.8 Intermediate Similarity NPC250315
0.8 Intermediate Similarity NPC469692
0.8 Intermediate Similarity NPC81419
0.7981 Intermediate Similarity NPC150923
0.7981 Intermediate Similarity NPC201718
0.798 Intermediate Similarity NPC129419
0.798 Intermediate Similarity NPC473448
0.7961 Intermediate Similarity NPC473326
0.7961 Intermediate Similarity NPC300584
0.7959 Intermediate Similarity NPC202672
0.7941 Intermediate Similarity NPC476315
0.7938 Intermediate Similarity NPC284902
0.7938 Intermediate Similarity NPC261721
0.7925 Intermediate Similarity NPC100487
0.7921 Intermediate Similarity NPC81386
0.7921 Intermediate Similarity NPC470010
0.7921 Intermediate Similarity NPC323008
0.7921 Intermediate Similarity NPC470013
0.7921 Intermediate Similarity NPC198853
0.7921 Intermediate Similarity NPC474035
0.7921 Intermediate Similarity NPC262133
0.7917 Intermediate Similarity NPC141193
0.7917 Intermediate Similarity NPC114979
0.7917 Intermediate Similarity NPC96259
0.7917 Intermediate Similarity NPC191476
0.7905 Intermediate Similarity NPC324017
0.7905 Intermediate Similarity NPC474747
0.7905 Intermediate Similarity NPC320019
0.7905 Intermediate Similarity NPC86077
0.7905 Intermediate Similarity NPC471148
0.7905 Intermediate Similarity NPC149371
0.79 Intermediate Similarity NPC12172
0.79 Intermediate Similarity NPC131209
0.79 Intermediate Similarity NPC30515
0.79 Intermediate Similarity NPC184463
0.79 Intermediate Similarity NPC20713
0.79 Intermediate Similarity NPC475925
0.79 Intermediate Similarity NPC133698
0.79 Intermediate Similarity NPC208886
0.7885 Intermediate Similarity NPC288876
0.7879 Intermediate Similarity NPC268298
0.7879 Intermediate Similarity NPC473564
0.7879 Intermediate Similarity NPC307092
0.7864 Intermediate Similarity NPC161493
0.7857 Intermediate Similarity NPC475703
0.7843 Intermediate Similarity NPC471492
0.7843 Intermediate Similarity NPC272050
0.7843 Intermediate Similarity NPC67584
0.7843 Intermediate Similarity NPC52044
0.7843 Intermediate Similarity NPC170120
0.7843 Intermediate Similarity NPC213698
0.7843 Intermediate Similarity NPC474947
0.7822 Intermediate Similarity NPC162205
0.7822 Intermediate Similarity NPC212486
0.7822 Intermediate Similarity NPC476300
0.7822 Intermediate Similarity NPC295204
0.7822 Intermediate Similarity NPC475302
0.7822 Intermediate Similarity NPC273579
0.7822 Intermediate Similarity NPC135776
0.7822 Intermediate Similarity NPC288240
0.7812 Intermediate Similarity NPC473390
0.7812 Intermediate Similarity NPC40746
0.7812 Intermediate Similarity NPC131669
0.7812 Intermediate Similarity NPC169575
0.7812 Intermediate Similarity NPC128429
0.781 Intermediate Similarity NPC474742
0.781 Intermediate Similarity NPC47880
0.781 Intermediate Similarity NPC472753
0.781 Intermediate Similarity NPC15993
0.781 Intermediate Similarity NPC469851
0.78 Intermediate Similarity NPC51004
0.78 Intermediate Similarity NPC476004
0.78 Intermediate Similarity NPC474761
0.78 Intermediate Similarity NPC71533
0.78 Intermediate Similarity NPC106510
0.78 Intermediate Similarity NPC469718
0.78 Intermediate Similarity NPC329857
0.7788 Intermediate Similarity NPC471145
0.7788 Intermediate Similarity NPC471144
0.7778 Intermediate Similarity NPC469653
0.7778 Intermediate Similarity NPC260343
0.7778 Intermediate Similarity NPC471047
0.7778 Intermediate Similarity NPC469628
0.7778 Intermediate Similarity NPC469631
0.7778 Intermediate Similarity NPC473658
0.7778 Intermediate Similarity NPC477513
0.7778 Intermediate Similarity NPC475906
0.7778 Intermediate Similarity NPC475819
0.7778 Intermediate Similarity NPC469853
0.7767 Intermediate Similarity NPC213078
0.7767 Intermediate Similarity NPC473291
0.7757 Intermediate Similarity NPC472756
0.7757 Intermediate Similarity NPC474741
0.7755 Intermediate Similarity NPC50637
0.7755 Intermediate Similarity NPC150755
0.7755 Intermediate Similarity NPC122502
0.7755 Intermediate Similarity NPC162071
0.7745 Intermediate Similarity NPC140543
0.7745 Intermediate Similarity NPC303942
0.7745 Intermediate Similarity NPC473316
0.7745 Intermediate Similarity NPC127019
0.7745 Intermediate Similarity NPC190294
0.7745 Intermediate Similarity NPC473330
0.7745 Intermediate Similarity NPC57405
0.7736 Intermediate Similarity NPC472754
0.7732 Intermediate Similarity NPC476804
0.7723 Intermediate Similarity NPC473321
0.7723 Intermediate Similarity NPC261607
0.7723 Intermediate Similarity NPC300312
0.7723 Intermediate Similarity NPC111114
0.7714 Intermediate Similarity NPC475053
0.7708 Intermediate Similarity NPC229825
0.77 Intermediate Similarity NPC166919
0.77 Intermediate Similarity NPC307411
0.77 Intermediate Similarity NPC474032
0.77 Intermediate Similarity NPC64913
0.77 Intermediate Similarity NPC212598
0.77 Intermediate Similarity NPC242877
0.77 Intermediate Similarity NPC51358
0.7685 Intermediate Similarity NPC472751
0.7685 Intermediate Similarity NPC469852
0.7685 Intermediate Similarity NPC166115
0.7685 Intermediate Similarity NPC472749
0.7685 Intermediate Similarity NPC243998
0.7679 Intermediate Similarity NPC469496
0.7679 Intermediate Similarity NPC469454
0.7679 Intermediate Similarity NPC469463
0.767 Intermediate Similarity NPC471142
0.767 Intermediate Similarity NPC473334
0.767 Intermediate Similarity NPC107476
0.767 Intermediate Similarity NPC471141
0.7664 Intermediate Similarity NPC472747
0.7664 Intermediate Similarity NPC472750
0.766 Intermediate Similarity NPC93763
0.766 Intermediate Similarity NPC108816
0.7658 Intermediate Similarity NPC179798

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC189609 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7615 Intermediate Similarity NPD7899 Clinical (unspecified phase)
0.7573 Intermediate Similarity NPD5282 Discontinued
0.7333 Intermediate Similarity NPD1698 Clinical (unspecified phase)
0.7282 Intermediate Similarity NPD7838 Discovery
0.7282 Intermediate Similarity NPD46 Approved
0.7282 Intermediate Similarity NPD6698 Approved
0.7257 Intermediate Similarity NPD6371 Approved
0.7228 Intermediate Similarity NPD4249 Approved
0.7188 Intermediate Similarity NPD4756 Discovery
0.7184 Intermediate Similarity NPD1695 Approved
0.7157 Intermediate Similarity NPD4250 Approved
0.7157 Intermediate Similarity NPD4251 Approved
0.713 Intermediate Similarity NPD8029 Clinical (unspecified phase)
0.71 Intermediate Similarity NPD7154 Phase 3
0.7048 Intermediate Similarity NPD7983 Approved
0.7043 Intermediate Similarity NPD8413 Clinical (unspecified phase)
0.6983 Remote Similarity NPD6053 Discontinued
0.6961 Remote Similarity NPD1733 Clinical (unspecified phase)
0.6952 Remote Similarity NPD5785 Approved
0.6822 Remote Similarity NPD5779 Approved
0.6822 Remote Similarity NPD5778 Approved
0.6796 Remote Similarity NPD5363 Approved
0.6783 Remote Similarity NPD6686 Approved
0.6667 Remote Similarity NPD4225 Approved
0.6607 Remote Similarity NPD6648 Approved
0.6602 Remote Similarity NPD6110 Phase 1
0.6602 Remote Similarity NPD5362 Discontinued
0.6549 Remote Similarity NPD5344 Discontinued
0.6505 Remote Similarity NPD4752 Clinical (unspecified phase)
0.6505 Remote Similarity NPD4269 Approved
0.6505 Remote Similarity NPD4270 Approved
0.6486 Remote Similarity NPD7839 Suspended
0.6476 Remote Similarity NPD6082 Clinical (unspecified phase)
0.6476 Remote Similarity NPD1694 Approved
0.6471 Remote Similarity NPD4821 Approved
0.6471 Remote Similarity NPD4820 Approved
0.6471 Remote Similarity NPD4819 Approved
0.6471 Remote Similarity NPD4822 Approved
0.6471 Remote Similarity NPD5790 Clinical (unspecified phase)
0.646 Remote Similarity NPD7640 Approved
0.646 Remote Similarity NPD7639 Approved
0.6429 Remote Similarity NPD6083 Phase 2
0.6429 Remote Similarity NPD6084 Phase 2
0.6415 Remote Similarity NPD5786 Approved
0.641 Remote Similarity NPD5697 Approved
0.6408 Remote Similarity NPD5369 Approved
0.64 Remote Similarity NPD8515 Approved
0.64 Remote Similarity NPD8516 Approved
0.64 Remote Similarity NPD8517 Approved
0.64 Remote Similarity NPD8513 Phase 3
0.6396 Remote Similarity NPD5695 Phase 3
0.6387 Remote Similarity NPD2067 Discontinued
0.6372 Remote Similarity NPD7638 Approved
0.6372 Remote Similarity NPD5696 Approved
0.6356 Remote Similarity NPD7320 Approved
0.6356 Remote Similarity NPD6881 Approved
0.6356 Remote Similarity NPD6899 Approved
0.6346 Remote Similarity NPD6435 Approved
0.6346 Remote Similarity NPD5209 Approved
0.6343 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6341 Remote Similarity NPD7115 Discovery
0.6336 Remote Similarity NPD7260 Phase 2
0.6333 Remote Similarity NPD6650 Approved
0.6333 Remote Similarity NPD6649 Approved
0.6325 Remote Similarity NPD5739 Approved
0.6325 Remote Similarity NPD6402 Approved
0.6325 Remote Similarity NPD7128 Approved
0.6325 Remote Similarity NPD6675 Approved
0.6311 Remote Similarity NPD4252 Approved
0.6303 Remote Similarity NPD6012 Approved
0.6303 Remote Similarity NPD6373 Approved
0.6303 Remote Similarity NPD6013 Approved
0.6303 Remote Similarity NPD6372 Approved
0.6303 Remote Similarity NPD4061 Clinical (unspecified phase)
0.6303 Remote Similarity NPD6014 Approved
0.6288 Remote Similarity NPD6845 Suspended
0.6275 Remote Similarity NPD4268 Approved
0.6275 Remote Similarity NPD5784 Clinical (unspecified phase)
0.6275 Remote Similarity NPD4271 Approved
0.6273 Remote Similarity NPD7637 Suspended
0.6271 Remote Similarity NPD5701 Approved
0.625 Remote Similarity NPD7102 Approved
0.625 Remote Similarity NPD6883 Approved
0.625 Remote Similarity NPD7290 Approved
0.625 Remote Similarity NPD5955 Clinical (unspecified phase)
0.625 Remote Similarity NPD7492 Approved
0.6239 Remote Similarity NPD5764 Clinical (unspecified phase)
0.6239 Remote Similarity NPD6101 Approved
0.6226 Remote Similarity NPD6400 Clinical (unspecified phase)
0.6218 Remote Similarity NPD6011 Approved
0.6202 Remote Similarity NPD6616 Approved
0.6198 Remote Similarity NPD8130 Phase 1
0.6198 Remote Similarity NPD6847 Approved
0.6198 Remote Similarity NPD6869 Approved
0.6198 Remote Similarity NPD6617 Approved
0.619 Remote Similarity NPD6054 Approved
0.619 Remote Similarity NPD6319 Approved
0.6186 Remote Similarity NPD6008 Approved
0.6154 Remote Similarity NPD5368 Approved
0.6154 Remote Similarity NPD7078 Approved
0.6154 Remote Similarity NPD8074 Phase 3
0.6148 Remote Similarity NPD8297 Approved
0.6148 Remote Similarity NPD6882 Approved
0.6146 Remote Similarity NPD3704 Approved
0.6142 Remote Similarity NPD6016 Approved
0.6142 Remote Similarity NPD6015 Approved
0.6136 Remote Similarity NPD6007 Clinical (unspecified phase)
0.6132 Remote Similarity NPD5331 Approved
0.6132 Remote Similarity NPD5332 Approved
0.6126 Remote Similarity NPD5693 Phase 1
0.6126 Remote Similarity NPD6411 Approved
0.6111 Remote Similarity NPD5279 Phase 3
0.6107 Remote Similarity NPD7736 Approved
0.6098 Remote Similarity NPD4632 Approved
0.6095 Remote Similarity NPD4790 Discontinued
0.6094 Remote Similarity NPD6370 Approved
0.6094 Remote Similarity NPD5988 Approved
0.6094 Remote Similarity NPD8080 Discontinued
0.608 Remote Similarity NPD6009 Approved
0.6077 Remote Similarity NPD7507 Approved
0.6075 Remote Similarity NPD7338 Clinical (unspecified phase)
0.6071 Remote Similarity NPD6399 Phase 3
0.6068 Remote Similarity NPD5211 Phase 2
0.6063 Remote Similarity NPD6059 Approved
0.6042 Remote Similarity NPD2685 Clinical (unspecified phase)
0.6036 Remote Similarity NPD5692 Phase 3
0.6032 Remote Similarity NPD7641 Discontinued
0.6031 Remote Similarity NPD8293 Discontinued
0.6019 Remote Similarity NPD1696 Phase 3
0.6016 Remote Similarity NPD5983 Phase 2
0.6016 Remote Similarity NPD7503 Approved
0.6 Remote Similarity NPD5737 Approved
0.6 Remote Similarity NPD5954 Clinical (unspecified phase)
0.6 Remote Similarity NPD6274 Approved
0.6 Remote Similarity NPD6672 Approved
0.6 Remote Similarity NPD690 Clinical (unspecified phase)
0.6 Remote Similarity NPD4695 Discontinued
0.5982 Remote Similarity NPD5284 Approved
0.5982 Remote Similarity NPD5694 Approved
0.5982 Remote Similarity NPD5281 Approved
0.5982 Remote Similarity NPD6050 Approved
0.5981 Remote Similarity NPD6695 Phase 3
0.598 Remote Similarity NPD8039 Approved
0.5966 Remote Similarity NPD5141 Approved
0.5965 Remote Similarity NPD5210 Approved
0.5965 Remote Similarity NPD4629 Approved
0.5954 Remote Similarity NPD8273 Phase 1
0.5952 Remote Similarity NPD7500 Approved
0.595 Remote Similarity NPD5345 Clinical (unspecified phase)
0.5946 Remote Similarity NPD7285 Clinical (unspecified phase)
0.5946 Remote Similarity NPD4753 Phase 2
0.5946 Remote Similarity NPD5370 Suspended
0.594 Remote Similarity NPD7319 Approved
0.5938 Remote Similarity NPD7299 Clinical (unspecified phase)
0.5935 Remote Similarity NPD2204 Approved
0.5935 Remote Similarity NPD6401 Clinical (unspecified phase)
0.5932 Remote Similarity NPD7632 Discontinued
0.5923 Remote Similarity NPD7830 Approved
0.5923 Remote Similarity NPD7642 Approved
0.5923 Remote Similarity NPD7604 Phase 2
0.5923 Remote Similarity NPD7829 Approved
0.5918 Remote Similarity NPD4247 Clinical (unspecified phase)
0.5897 Remote Similarity NPD5286 Approved
0.5897 Remote Similarity NPD4696 Approved
0.5897 Remote Similarity NPD5285 Approved
0.5893 Remote Similarity NPD5207 Approved
0.5891 Remote Similarity NPD6291 Clinical (unspecified phase)
0.5891 Remote Similarity NPD8274 Clinical (unspecified phase)
0.5888 Remote Similarity NPD4800 Clinical (unspecified phase)
0.5882 Remote Similarity NPD6647 Phase 2
0.5868 Remote Similarity NPD6412 Phase 2
0.5862 Remote Similarity NPD7902 Approved
0.5862 Remote Similarity NPD4755 Approved
0.5859 Remote Similarity NPD7100 Approved
0.5859 Remote Similarity NPD7101 Approved
0.5849 Remote Similarity NPD8259 Clinical (unspecified phase)
0.5841 Remote Similarity NPD4810 Clinical (unspecified phase)
0.5833 Remote Similarity NPD2664 Clinical (unspecified phase)
0.5833 Remote Similarity NPD8451 Approved
0.5833 Remote Similarity NPD6336 Discontinued
0.5827 Remote Similarity NPD7505 Discontinued
0.5827 Remote Similarity NPD6317 Approved
0.5816 Remote Similarity NPD6108 Clinical (unspecified phase)
0.5806 Remote Similarity NPD7116 Clinical (unspecified phase)
0.5804 Remote Similarity NPD6904 Approved
0.5804 Remote Similarity NPD6080 Approved
0.5804 Remote Similarity NPD6673 Approved
0.5802 Remote Similarity NPD8328 Phase 3
0.5798 Remote Similarity NPD5224 Approved
0.5798 Remote Similarity NPD5225 Approved
0.5798 Remote Similarity NPD5226 Approved
0.5798 Remote Similarity NPD4633 Approved
0.5789 Remote Similarity NPD8448 Approved
0.5781 Remote Similarity NPD6335 Approved
0.5781 Remote Similarity NPD6313 Approved
0.5781 Remote Similarity NPD7327 Approved
0.5781 Remote Similarity NPD7328 Approved
0.5781 Remote Similarity NPD6314 Approved
0.5778 Remote Similarity NPD5956 Approved
0.5769 Remote Similarity NPD8444 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data